BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27730355)

  • 1. Allogenic Blood Transfusion is Associated with Poor Perioperative and Long-Term Outcome in Esophageal Cancer.
    Reeh M; Ghadban T; Dedow J; Vettorazzi E; Uzunoglu FG; Nentwich M; Kluge S; Izbicki JR; Vashist YK
    World J Surg; 2017 Jan; 41(1):208-215. PubMed ID: 27730355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of perioperative blood transfusion on the long-term survival of patients undergoing esophagectomy for esophageal cancer: a systematic review and meta-analysis.
    Boshier PR; Ziff C; Adam ME; Fehervari M; Markar SR; Hanna GB
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29267869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer.
    Takemura M; Osugi H; Higashino M; Takada N; Lee S; Kinoshita H
    Ann Thorac Cardiovasc Surg; 2005 Oct; 11(5):293-300. PubMed ID: 16299455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal Cancer.
    Reeh M; Metze J; Uzunoglu FG; Nentwich M; Ghadban T; Wellner U; Bockhorn M; Kluge S; Izbicki JR; Vashist YK
    Medicine (Baltimore); 2016 Feb; 95(7):e2724. PubMed ID: 26886613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of autologous instead of allogeneic blood transfusion during esophagectomy prolongs disease-free survival among patients with recurrent esophageal cancer.
    Motoyama S; Okuyama M; Kitamura M; Saito R; Kamata S; Murata K; Ogawa J
    J Surg Oncol; 2004 Jul; 87(1):26-31. PubMed ID: 15221916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative blood transfusion: does it influence survival and cancer progression in metastatic spine tumor surgery?
    Zaw AS; Kantharajanna SB; Maharajan K; Tan B; Vellayappan B; Kumar N
    Transfusion; 2017 Feb; 57(2):440-450. PubMed ID: 27878812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer.
    Melis M; McLoughlin JM; Dean EM; Siegel EM; Weber JM; Shah N; Kelley ST; Karl RC
    J Surg Res; 2009 May; 153(1):114-20. PubMed ID: 19201421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma.
    Lee PC; Mirza FM; Port JL; Stiles BM; Paul S; Christos P; Altorki NK
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1196-206. PubMed ID: 21397267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of perioperative blood transfusion on survival after esophageal resection for carcinoma.
    Langley SM; Alexiou C; Bailey DH; Weeden DF
    Ann Thorac Surg; 2002 Jun; 73(6):1704-9. PubMed ID: 12078756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy.
    Yamashita K; Watanabe M; Mine S; Kurogochi T; Okamura A; Hayami M; Imamura Y
    World J Surg; 2017 Sep; 41(9):2337-2344. PubMed ID: 28432391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative blood transfusion has no effect on overall survival after esophageal resection for esophageal squamous cell carcinoma: A retrospective cohort study.
    Liu J; Chen S; Chen Y; Wang N; Ye X
    Int J Surg; 2018 Jul; 55():24-30. PubMed ID: 29578096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.
    Tachibana M; Tabara H; Kotoh T; Kinugasa S; Dhar DK; Hishikawa Y; Masunaga R; Kubota H; Nagasue N
    Am J Gastroenterol; 1999 Mar; 94(3):757-65. PubMed ID: 10086663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between red blood cell transfusion and long-term mortality in patients with cancer of the esophagus after esophagectomy.
    Lee J; Chin JH; Kim JI; Lee EH; Choi IC
    Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29077842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of autologous blood transfusion for avoiding allogenic transfusion and infectious complications after esophageal cancer resection.
    Kinoshita Y; Udagawa H; Tsutsumi K; Ueno M; Nakamura T; Akiyama H; Takahashi K; Kajiyama Y; Tsurumaru M
    Surgery; 2000 Feb; 127(2):185-92. PubMed ID: 10686984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of esophagectomy for primary malignant melanoma of the esophagus: a single-institute retrospective analysis.
    Harada K; Mine S; Yamada K; Shigaki H; Oya S; Baba H; Watanabe M
    Dis Esophagus; 2016 May; 29(4):314-9. PubMed ID: 25708974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with early recurrence and death after esophagectomy for cancer.
    Davies AR; Pillai A; Sinha P; Sandhu H; Adeniran A; Mattsson F; Choudhury A; Forshaw MJ; Gossage JA; Lagergren J; Allum WH; Mason RC
    J Surg Oncol; 2014 Apr; 109(5):459-64. PubMed ID: 24301461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival after multimodality therapy including surgery for metastatic esophageal cancer.
    Van Daele E; Scuderi V; Pape E; Van de Putte D; Varin O; Van Nieuwenhove Y; Ceelen W; Troisi R; Pattyn P
    Acta Chir Belg; 2018 Aug; 118(4):227-232. PubMed ID: 29258384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal cancer patients surviving 6 years after esophagectomy.
    Tachibana M; Dhar DK; Kinugasa S; Yoshimura H; Fujii T; Shibakita M; Ohno S; Ueda S; Kohno H; Nagasue N
    Langenbecks Arch Surg; 2002 Jun; 387(2):77-83. PubMed ID: 12111259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer.
    Nishi T; Takeuchi H; Matsuda S; Ogura M; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
    World J Surg Oncol; 2015 Aug; 13():232. PubMed ID: 26231560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
    Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.